Search Results 2681-2690 of 15493 for Humira
A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), ...
Alzheimer's disease is a progressive neurologic disorder that causes memory loss and other cognitive decline due to brain cell degeneration.
Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.
October is Breast Cancer Awareness Month JACKSONVILLE, Florida — There are two surgical options to treat breast cancer: lumpectomy and mastectomy.
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
The purpose of this research study is to determine how well neratinib works in treating breast cancer that has spread to the brain. Neratinib is a recently ...
Note: November is National Epilepsy Awareness Month. Using deep brain stimulation techniques, neuroscientists at Mayo Clinic are looking for early signals ...
The purpose of this study is to compare the objective response rate (ORR) by IRR of ripretinib vs sunitinib using modified Response Evaluation Criteria in Solid ...
The purpose of this study is to evaluate the randomized controlled mixed methods of a Virtual Reality (VR) exposure therapy system in patients with anxiety and ...
The purpose of this study is to evaluate time to return of lower extremity motor function following mepivacaine versys low-dose bupivacaine spinal anesthetic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.